
Sign up to save your podcasts
Or


In the first episode of our second season, hosts David Anderson and Gina Vitale travel back in time to relive three historical moments that led to blockbuster drugs like Ozempic and Wegovy. They also talk with C&EN reporter Aayushi Pratap about how future GLP-1 drugs may expand on the current slate of options.
C&EN's latest podcast, Inflection Point, leans on our 100-year archive to trace headline topics in science today back to their disparate and surprising roots. In each episode, we explore three lesser-known moments in science history that ultimately led us to current-day breakthroughs. With help from expert C&EN reporters, this new show examines how discoveries from our past have shaped our present and will change our future.
Subscribe to Inflection Point now on Apple Podcasts, Spotify, or wherever you get your podcasts.
By Chemical & Engineering News4.8
7070 ratings
In the first episode of our second season, hosts David Anderson and Gina Vitale travel back in time to relive three historical moments that led to blockbuster drugs like Ozempic and Wegovy. They also talk with C&EN reporter Aayushi Pratap about how future GLP-1 drugs may expand on the current slate of options.
C&EN's latest podcast, Inflection Point, leans on our 100-year archive to trace headline topics in science today back to their disparate and surprising roots. In each episode, we explore three lesser-known moments in science history that ultimately led us to current-day breakthroughs. With help from expert C&EN reporters, this new show examines how discoveries from our past have shaped our present and will change our future.
Subscribe to Inflection Point now on Apple Podcasts, Spotify, or wherever you get your podcasts.

90,956 Listeners

21,959 Listeners

44,008 Listeners

32,309 Listeners

38,812 Listeners

26,252 Listeners

764 Listeners

12,155 Listeners

822 Listeners

6,483 Listeners

16,473 Listeners

6,583 Listeners

2,322 Listeners

1,374 Listeners

18 Listeners